CoChat

Impact of Body Composition During Neoadjuvant Chemoradiotherapy on Complications, Survival and Tumor Response in Patients With Locally Advanced Rectal Cancer

Liu, Zhenzhen, Lu, Siyi, Wang, Yuxia, Lin, Xinyi, Ran, Peng, Zhou, Xin, Fu, Wei, Wang, Hao · 2022 · Frontiers in Nutrition
Cited by 19

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Background: To explore the impact of body composition before neoadjuvant chemoradiotherapy (pre-NCRT) and after neoadjuvant chemoradiotherapy (post-NCRT) on complications, survival, and tumor response in patients with locally advanced rectal cancer (LARC). Methods: Patients with LARC who underwent radical surgery after NCRT between Ja 22nuary 2012 and March 2019 were studied. Body composition parameters, including skeletal muscle area (SMA), muscle density (MD), visceral fat area (VFA), total abdominal fat area (TAFA), and subcutaneous fat area (SFA), was identified at the third lumbar vertebra level on computed tomography (CT). The patients were divided into two groups based on the sex-specific quartile values of SMA, MD, VFA, TAFA, SFA, and body composition change. Patient characteristics, short- and long-term postoperative complications, survival, and tumor response were analyzed. Results: A total of 122 eligible patients were enrolled. Body composition parameters, except MD, were strongly correlated with BMI (p < 0.001). Pre-NCRT low MD (p = 0.04) and TAFA loss (p = 0.02) were significantly correlated with short- and long-term ileus, respectively. Pre-NCRT low SMA was a significant prognostic factor for both disease-free survival (DFS) (HR 2.611, 95% CI 1.129–6.040, p = 0.025) and cancer-specific survival (CSS) (HR 3.124, 95% CI 1.030–9.472, p = 0.044) in the Cox regression multivariate analysis. Multivariate logistic regression analysis identified post-NCRT SFA (OR 3.425, 95% CI 1.392–8.427, p = 0.007) and SFA loss (OR 3.358, 95% CI 1.214–9.289, p = 0.02) as independent risk factors for tumor regression grade (TRG) and downstaging, respectively. Conclusion: Pre-NCRT low MD and TAFA loss were related to a high incidence of short- and long-term ileus, respectively. Pre-NCRT low SMA was a significant prognostic factor for CSS and DFS. Post-NCRT SFA and SFA loss were independent risk factors for TRG and downstaging, respectively.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fnut.2022.796601

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 38

  1. Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin., 68, 394, 10.3322/caac.21492 · DOI · Paper page
  2. Siegel, 2020, Colorectal cancer statistics, 2020, CA Cancer J Clin., 70, 145, 10.3322/caac.21601 · DOI · Paper page
  3. Fleshman, 2019, Disease-free survival and local recurrence for laparoscopic resection compared with open resection of stage II to III rectal cancer: follow-up results of the ACOSOG Z6051 randomized controlled trial, Ann Surg., 269, 589, 10.1097/SLA.0000000000003002 · doi:10.1097/sla.0000000000003002
  4. Voss, 2020, Adjuvant chemotherapy does not improve recurrence-free survival in patients with stage 2 or stage 3 rectal cancer after neoadjuvant chemoradiotherapy and total mesorectal excision, Dis Colon Rectum., 63, 427, 10.1097/DCR.0000000000001558 · DOI
  5. Fleming, 2011, Neoadjuvant therapy in rectal cancer, Dis Colon Rectum., 54, 901, 10.1007/DCR.0b013e31820eeb37 · DOI
  6. Rullier, 2010, Impact of tumor response on survival after radiochemotherapy in locally advanced rectal carcinoma, Am J Surg Pathol., 34, 562, 10.1097/PAS.0b013e3181d438b0 · DOI
  7. Maas, 2011, Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer, J Clin Oncol., 29, 4633, 10.1200/JCO.2011.37.7176 · DOI · Paper page
  8. Tobert, 2017, Emerging impact of malnutrition on surgical patients: literature review and potential implications for cystectomy in bladder cancer, J Urol., 198, 511, 10.1016/j.juro.2017.01.087 · DOI
  9. Marshall, 2019, Prevalence of malnutrition and impact on clinical outcomes in cancer services: a comparison of two time points, Clin Nutr., 38, 644, 10.1016/j.clnu.2018.04.007 · DOI · Paper page
  10. Antoun, 2010, Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma, Ann Oncol., 21, 1594, 10.1093/annonc/mdp605 · DOI · Paper page
  11. Lu, 2020, Preoperative fibrinogen-albumin ratio index (FARI) is a reliable prognosis and chemoradiotherapy sensitivity predictor in locally advanced rectal cancer patients undergoing radical surgery following neoadjuvant chemoradiotherapy, Cancer Manag Res., 12, 8555, 10.2147/CMAR.S273065 · DOI
  12. Prado, 2009, Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment, Clin Cancer Res., 15, 2920, 10.1158/1078-0432.CCR-08-2242 · DOI · Paper page
  13. Feliciano, 2017, Association of systemic inflammation and sarcopenia with survival in nonmetastatic colorectal cancer: results from the C SCANS Study, JAMA Oncol., 3, e172319, 10.1001/jamaoncol.2017.2319 · DOI · Paper page
  14. Lu, 2021, High CFP score indicates poor prognosis and chemoradiotherapy response in LARC patients, Cancer Cell Int., 21, 205, 10.1186/s12935-021-01903-1 · DOI
  15. Hsueh, 2019, Significance of the glasgow prognostic score in predicting the postoperative outcome of patients with stage III gastric cancer, J Clin Med, 8, 1448, 10.3390/jcm8091448 · DOI
  16. Almasaudi, 2020, Hypoalbuminemia reflects nutritional risk, body composition and systemic inflammation and is independently associated with survival in patients with colorectal cancer, Cancers, 12, 1986, 10.3390/cancers12071986 · DOI · Paper page
  17. Anandavadivelan, 2016, Cachexia in patients with oesophageal cancer, Nat Rev Clin Oncol., 13, 185, 10.1038/nrclinonc.2015.200 · DOI · Paper page
  18. Hotouras, 2016, The influence of obesity and body mass index on the outcome of laparoscopic colorectal surgery: a systematic literature review, Colorectal Dis., 18, O337, 10.1111/codi.13406 · DOI
  19. Fujiwara, 2015, Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma, J Hepatol., 63, 131, 10.1016/j.jhep.2015.02.031 · DOI · Paper page
  20. Bandera, 2018, Obesity, body composition, and breast cancer: an evolving science, JAMA Oncol., 4, 804, 10.1001/jamaoncol.2018.0125 · DOI
  21. Vrieling, 2018, Body composition in relation to clinical outcomes in renal cell cancer: a systematic review and meta-analysis, Eur Urol Focus., 4, 420, 10.1016/j.euf.2016.11.009 · DOI
  22. Bundred, 2019, Body composition assessment and sarcopenia in patients with pancreatic cancer: a systematic review and meta-analysis, HPB., 21, 1603, 10.1016/j.hpb.2019.05.018 · DOI
  23. Nattenmüller, 2019, CT-Quantified Adipose Tissue Distribution: Risk or Protective Factor for Complications after Rectal Cancer Surgery?, Obes Facts., 12, 259, 10.1159/000499320 · DOI
  24. Chung, 2020, Prognostic significance of sarcopenia and skeletal muscle mass change during preoperative chemoradiotherapy in locally advanced rectal cancer, Clin Nutr., 39, 820, 10.1016/j.clnu.2019.03.014 · DOI
  25. Miyamoto, 2015, Sarcopenia is a negative prognostic factor after curative resection of colorectal cancer, Ann Surg Oncol., 22, 2663, 10.1245/s10434-014-4281-6 · DOI · Paper page
  26. Clavien, 2009, The Clavien-Dindo classification of surgical complications: five-year experience, Ann Surg., 250, 187, 10.1097/SLA.0b013e3181b13ca2 · DOI · Paper page
  27. Sheikhbahaei, 2021, CT-based assessment of body composition following neoadjuvant chemohormonal therapy in patients with castration-naive oligometastatic prostate cancer, Prostate., 81, 127, 10.1002/pros.24088 · DOI
  28. De Nardi, 2020, Changes in body composition during neoadjuvant therapy can affect prognosis in rectal cancer patients: an exploratory study, Curr Probl Cancer., 44, 100510, 10.1016/j.currproblcancer.2019.100510 · DOI · Paper page
  29. Xiao, 2020, Association of low muscle mass and low muscle radiodensity with morbidity and mortality for colon cancer surgery, JAMA Surg., 155, 942, 10.1001/jamasurg.2020.2497 · DOI · Paper page
  30. Heus, 2021, Visceral obesity and muscle mass determined by CT scan and surgical outcome in patients with advanced ovarian cancer. A retrospective cohort study, Gynecol Oncol., 160, 187, 10.1016/j.ygyno.2020.10.015 · DOI
  31. Choi, 2018, Sarcopenia is negatively associated with long-term outcomes in locally advanced rectal cancer, J Cachexia Sarcopenia Muscle., 9, 53, 10.1002/jcsm.12234 · DOI · Paper page
  32. Levolger, 2018, Muscle wasting and survival following pre-operative chemoradiotherapy for locally advanced rectal carcinoma, Clin Nutr., 37, 1728, 10.1016/j.clnu.2017.06.028 · DOI
  33. Baastrup, 2020, Visceral obesity and short-term outcomes after laparoscopic rectal cancer resection, Surg Endosc., 34, 177, 10.1007/s00464-019-06748-4 · DOI
  34. Iwase, 2021, Body composition and breast cancer risk and treatment: mechanisms and impact, Breast Cancer Res Treat., 186, 273, 10.1007/s10549-020-06092-5 · DOI
  35. Lin, 2021, Body composition parameters predict pathological response and outcomes in locally advanced gastric cancer after neoadjuvant treatment: a multicenter, international study, Clin Nutr., 40, 4980, 10.1016/j.clnu.2021.06.021 · DOI
  36. Omarini, 2019, Predictive role of body composition parameters in operable breast cancer patients treated with neoadjuvant chemotherapy, Cancer Manag Res., 11, 9563, 10.2147/CMAR.S216034 · DOI
  37. Shu, 2014, Clinical and prognostic significance of preoperative plasma hyperfibrinogenemia in gallbladder cancer patients following surgical resection: a retrospective and in vitro study, BMC Cancer., 14, 566, 10.1186/1471-2407-14-566 · DOI
  38. Gnanendran, 2020, Acquired lipodystrophy associated with immune checkpoint inhibitors, Melanoma Res., 30, 599, 10.1097/CMR.0000000000000660 · DOI

Cited by

See all 19

Metadata

Authors
Liu, Z., Lu, S., Wang, Y., Lin, X., Ran, P., Zhou, X., Fu, W., & Wang, H.
Venue
Frontiers in Nutrition
Published
2022-01-27
Volume
9
ISSN
2296-861X
Cited by
19
References
3
Funders
  • National Natural Science Foundation of China (81972702, 91959110)
  • Natural Science Foundation of Beijing Municipality (7204324)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impact of Body Composition During Neoadjuvant Chemoradiotherapy on Complications, Survival and Tumor Response in Patients With Locally Advanced Rectal Cancer. https://app.cochat.ai/papers/10.3389/fnut.2022.796601
The paper
Liu, Z., Lu, S., Wang, Y., Lin, X., Ran, P., Zhou, X., Fu, W., & Wang, H. (2022). Impact of Body Composition During Neoadjuvant Chemoradiotherapy on Complications, Survival and Tumor Response in Patients With Locally Advanced Rectal Cancer. Frontiers in Nutrition. https://doi.org/10.3389/fnut.2022.796601

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.